Adults taking GLP-1 drugs consume 21 percent fewer calories and spend nearly a third less on grocery bills, according to KPMG data cited by CNBC. JPMorgan estimates that GLP-1 users spend about 5 percent less at quick-service restaurants. [1] The numbers are rewriting the economics of American dining.

Olive Garden and the Cheesecake Factory have both introduced smaller-portion menus, according to Fortune, with GLP-1 users as one explicit consideration. [2] The trend is broader than any single chain. Tasting Table reported that restaurant menus across the industry are pivoting toward nutrient-dense, protein-forward dishes designed for appetites that have fundamentally changed. [3] NBC News described the shift as chains "quietly redesigning" their menus around smaller portions and higher protein content. [4]

The Economist, writing in December, noted that upscale restaurants from London to Dubai had already launched mini menus. The American casual dining segment is following, but the adjustment carries risk: the industry's value proposition has been built on portion size for decades. KPMG's data suggests the 40 percent calorie reduction among GLP-1 users is not a diet choice but a physiological reality — these customers cannot eat what they used to order.

Food industry executives are warning that the impact is "lasting," not cyclical. [5]

-- MAYA CALLOWAY, New York